Verrica Pharmaceuticals (VRCA) had the highest return last month by a US stock in the Pharmaceuticals Industry, returning 145.9%.

ASSET	MONTH	% RETURN
Verrica Pharmaceuticals (VRCA)	November 2025	145.95%
Evoke Pharma (EVOK)	November 2025	113.33%
Relmada Therapeutics (RLMD)	November 2025	103.15%
Terns Pharmaceuticals (TERN)	November 2025	100.07%
TherapeuticsMD (TXMD)	November 2025	45.3%
Septerna, Inc Common Stock (SEPN)	November 2025	42.12%
Milestone Pharmaceuticals (MIST)	November 2025	37.95%
Theravance Biopharma (TBPH)	November 2025	37.63%
Omeros (OMER)	November 2025	34.4%
Teva Pharma Industries Ltd ADR (TEVA)	November 2025	30.53%
Collegium Pharmaceutical (COLL)	November 2025	30.06%
Lipocine (LPCN)	November 2025	29.32%
Jazz Pharmaceuticals (JAZZ)	November 2025	28.64%
BioAge Labs (BIOA)	November 2025	26.7%
Fulcrum Therapeutics (FULC)	November 2025	26.33%
Eli Lilly and (LLY)	November 2025	24.29%
Arvinas (ARVN)	November 2025	24.11%
Harmony Biosciences (HRMY)	November 2025	23.82%
Scilex (SCLX)	November 2025	22.87%
Sol Gel Technologies (SLGL)	November 2025	22.59%
Oramed Pharmaceuticals (ORMP)	November 2025	22.32%
Axsome Therapeutics (AXSM)	November 2025	22.28%
Merck (MRK)	November 2025	22.22%
Kala Pharmaceuticals (KALA)	November 2025	20.76%
Liquidia Technologies (LQDA)	November 2025	20.34%